Interleukin-19 in Breast Cancer

Table 2

Associations between IL-19 expression in 143 breast invasive duct carcinoma tumors with other important clinicopathologic variables.

Parameters	Category	𝑛	IL-19-L^1	IL-19-H^2	𝑃
			(𝑛=68)	(𝑛=75)
Age (years)	<60	103	54	49	0.061
	≥60	40	14	26
Primary tumor (T)	T1	50	33	17	0.003*
	T2	78	32	46
	T3	10	3	7
	T4	5	0	5
Nodal status (N)	N0	71	42	29	0.001*
	N1	56	25	31
	N2	16	1	15
Stage	I	34	24	10	<0.001*
	II	87	41	46
	III	22	3	19
HER2 expression	Low (0+ to 2+)	103	56	47	0.009*
	High (3+)	40	12	28

1IL-19-L: low grade immunostaining, 𝐻 score <200.
2IL-19-H: high grade immunostaining, 𝐻 score ≥200.
3HER scoring was done using standard HercepTest guidelines.
∗Statistically significant.
The table refers to Hsing et al. [13].